Daniel J. George
机构：Duke University, Prostate Cancer Research, Duke Medical Center · ORCID：0000-0003-1499-7203
发表论文 581 篇 · 总被引 12782 次 · h-index 56
代表论文
- 3β-HSD1–Mediated Steroid Back-Conversion Maintains Androgen Signaling in Prostate Cancer (2026 · Molecular Cancer Research)
- Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801) (2026 · Journal of Clinical Oncology)
- Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes (2026 · Clinical Cancer Research)
- Real-world clinical outcomes, genetic testing patterns, and treatment patterns of patients with metastatic castration-resistant prostate cancer treated with olaparib monotherapy in the United States (2026 · Urologic Oncology Seminars and Original Investigations)
- What we can learn from a national tumor pathology registry (2025 · Cancer)
- Table S1 from PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer (2025)